Several bioinformatics papers and some reports from detecting clinical specimens have demonstrated that NLRC3 is associated with the prognosis and malignancy of tumors (include colorectal cancer, Hepatocellular carcinoma, Gastric cancer, Bladder cancer and lung adenocarcinoma) (46–52). This evidence concerns the gene NLRC3 and colorectal cancer.